Henlius’ Rituximab Results Bolster RA Ambitions In China

Reports Positive Phase III Data At National Congress Of Chinese Rheumatology

 
• By David Wallace
  
China Flag Thumbs Up
Henlius is hoping to secure Chinese approval for the RA indication • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products